Assembly Biosciences, Inc.
HealthcareNASDAQ:ASMB · NASDAQ Global Select
+$0.43 today
Vol 0.14M · Avg 0.14M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+36.26%
Period High
$38.50
Period Low
$16.85
Latest
$22.96
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Nautilus Biotechnology, Inc.
NASDAQ:NAUT
$284.66M
Enanta Pharmaceuticals, Inc.
NASDAQ:ENTA
$276.28M
Foghorn Therapeutics Inc.
NASDAQ:FHTX
$245.42M
Zura Bio Limited
NASDAQ:ZURA
$240.58M
Sagimet Biosciences Inc.
NASDAQ:SGMT
$211.13M
Arcturus Therapeutics Holdings Inc.
NASDAQ:ARCT
$198.11M
Immuneering Corporation
NASDAQ:IMRX
$152.11M
Tenaya Therapeutics, Inc.
NASDAQ:TNYA
$118.59M
Pyxis Oncology, Inc.
NASDAQ:PYXS
$111.51M
Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARD
$85.08M
What is the latest ASMB filing?
The latest filing shown is 4 dated Jun 5, 2026.
How many recent filings does ASMB have?
Intrinsic Alpha currently shows 20 recent filings for ASMB.
Explore More
Continue the stock analysis
Jump to another research area for this company.